Relief Therapeutics Holding SA (RLFTF)
1.44
+0.06
(+4.73%)
USD |
OTCM |
May 17, 14:26
Relief Therapeutics Shareholders Equity (Quarterly): 62.18M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 62.18M |
| June 30, 2023 | 104.94M |
| June 30, 2023 | 104.94M |
| December 31, 2022 | 156.84M |
| June 30, 2022 | 169.15M |
| June 30, 2022 | 169.15M |
| December 31, 2021 | 198.59M |
| June 30, 2021 | 134.92M |
| June 30, 2021 | 134.92M |
| December 31, 2020 | 76.74M |
| June 30, 2020 | 25.51M |
| June 30, 2020 | 25.51M |
| December 31, 2019 | 14.76M |
| June 30, 2019 | 21.22M |
| June 30, 2019 | 21.22M |
| December 31, 2018 | 21.62M |
| June 30, 2018 | 21.13M |
| June 30, 2018 | 21.13M |
| December 31, 2017 | 21.50M |
| June 30, 2017 | 22.95M |
| June 30, 2017 | 22.95M |
| December 31, 2016 | 21.85M |
| Date | Value |
|---|---|
| June 30, 2016 | 16.86M |
| June 30, 2016 | 16.86M |
| December 31, 2015 | -0.0536M |
| June 30, 2015 | 21.22M |
| June 30, 2015 | 21.22M |
| December 31, 2014 | 26.66M |
| June 30, 2014 | 21.64M |
| June 30, 2014 | 21.64M |
| December 31, 2013 | 22.63M |
| June 30, 2013 | -2.919M |
| June 30, 2013 | -2.919M |
| December 31, 2012 | 12.28M |
| June 30, 2012 | -1.759M |
| June 30, 2012 | -1.759M |
| December 31, 2011 | 13.32M |
| June 30, 2011 | 7.284M |
| December 31, 2010 | 56.03M |
| June 30, 2010 | 50.96M |
| December 31, 2009 | 54.78M |
| June 30, 2009 | 59.84M |
| December 31, 2008 | 64.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.76M
Minimum
Dec 2019
198.59M
Maximum
Dec 2021
94.70M
Average
104.94M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 160.35M |
| CRISPR Therapeutics AG | 2.084B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -8.834M |
| Molecular Partners AG | 210.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.95M |
| Total Liabilities (Quarterly) | 28.77M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 2.649 |
| Net Debt Paydown Yield | 0.01% |